Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AL › Mobile › NPI 1992939417
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $1.01M by Medicaid between May 2018 and Aug 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 95% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
MOBILE, AL 36603
33aNPI1992939417assigned 05/12/2009
28Total paid$1.01M
24GClaims10,160
24DCodes billed3
24AFirst – last monthMay 2018 – Aug 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Alabama

Rank by total paid#21 of 61
Median peer was paid$46K
This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration95% of spending on code U0003 with only 3 total codes billed. Highly concentrated billing profile.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201838$638.78
201942$682.92
2020941$94K
20215,477$547K
20223,662$365K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 95% 9,599 8,197 $960K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4.7% 481 462 $47K
87650 <1% 80 80 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.